Cancer clinical trials in the region Occitanie

174 currently recruiting clinical trials
Region Occitanie

Phase 2 Prostate cancer
#NCT04585750
Metastatic Castration-resistant TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
PMV Pharmaceuticals, Inc
Phase 2 Breast cancer
#NCT04585750
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
PMV Pharmaceuticals, Inc
Phase 2 Lung cancer
#NCT04585750
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
PMV Pharmaceuticals, Inc
Phase 2 Colon cancer Rectal cancer Anal cancer
#NCT04585750
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
PMV Pharmaceuticals, Inc
Phase 2 Pancreas cancer
#NCT04570943
Adenocarcinoma Locally Advanced Systemic Treatment-Naive Systemic Treatment-Naive None
6 main criterias to confirm
Institut du cancer de Montpellier (Montpellier), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Institut de cancérologie du Gard (Nîmes)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Lung cancer
#NCT04526782
NSCLC (Non-Small Cell Lung Cancer) Metastatic BRAF Surgery Chemotherapy Systemic Treatment-Naive Immunotherapy Chemotherapy 1
ALK EGFR ROS-1 Targeted therapy Targeted therapy
10 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier), Institut Sainte Catherine (Avignon), Centre Hospitalier François Mitterrand de Pau (Pau)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2 Colon cancer Rectal cancer Anal cancer
#NCT04268121
Neuroendocrine tumor Localized Systemic Treatment-Naive None
5 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2 Colon cancer Rectal cancer
#NCT04262687
Metastatic MSS Systemic Treatment-Naive Surgery Chemotherapy None 1
MSI/dMMR Immunotherapy Immunotherapy
8 main criterias to confirm
Centre Hospitalier de Béziers (Béziers), Centre Hospitalier de Perpignan (Perpignan), Centre Hospitalier Universitaire de Nîmes (Nîmes), Institut Sainte Catherine (Avignon), Centre Hospitalier d'Avignon (Avignon) (and 3 more...)
Fédération Francophone de Cancérologie Digestive
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer
#NCT04116541
Locally Advanced Metastatic Metastatic Castration-resistant ALK BRAF EGFR FGFR MET NTRK-1/2/3 RET ROS-1 SMAD4 Other mutation 1 2 3 or more
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse)
Centre Léon Bérard
Phase 2 Lung cancer
#NCT04042558
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced Metastatic ALK EGFR ROS-1 Chemotherapy Targeted therapy Radiotherapy Targeted therapy
7 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse)
Centre François Baclesse